DICP OpenIR
A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells
Shen, Zheyu1; Wu, Hao2; Yang, Sugeun3; Ma, Xuehua1; Li, Zihou1; Tan, Mingqian2; Wu, Aiguo1
关键词Trojan-horse Targeting Strategy Mri Contrast Agents Active Targetability To Cancer Cells Non-specific Uptake By Non-cancerous Cells
刊名BIOMATERIALS
2015-11-01
DOI10.1016/j.biomaterials.2015.08.022
70页:1-11
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Technology
类目[WOS]Engineering, Biomedical ; Materials Science, Biomaterials
研究领域[WOS]Engineering ; Materials Science
关键词[WOS]IRON-OXIDE NANOPARTICLES ; MRI CONTRAST AGENT ; DRUG-DELIVERY ; CANCER-THERAPY ; IN-VIVO ; N-ISOPROPYLACRYLAMIDE ; POLYMERIC MICELLE ; ANTICANCER DRUG ; LIVER-CANCER ; PH
英文摘要One big challenge with active targeting of nanocarriers is non-specific binding between targeting molecules and non-target moieties expressed on non-cancerous cells, which leads to non-specific uptake of nanocarriers by non-cancerous cells. Here, we propose a novel Trojan-horse targeting strategy to hide or expose the targeting molecules of nanocarriers on-demand. The non-specific uptake by non-cancerous cells can be reduced because the targeting molecules are hidden in hydrophilic polymers. The nanocarriers are still actively targetable to cancer cells because the targeting molecules can be exposed on-demand at tumor regions. Typically, Fe3O4 nanocrystals (FN) as magnetic resonance imaging (Mm) contrast agents were encapsulated into albumin nanopartides (AN), and then folic acid (FA) and pH-sensitive polymers (PP) were grafted onto the surface of AN-FN to construct PP-FA-AN-FN nanoparticles. Fourier transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), transmission electron microscope (TEM) and gel permeation chromatography (GPC) results confirm successful construction of PP-FA-AN-FN. According to difference of nanoparticle-cellular uptake between pH 7.4 and 5.5, the weight ratio of conjugated PP to nanoparticle FA-AN-FN (i.e. graft density) and the molecular weight of PP (i.e. graft length) are optimized to be 132 and 5.7 kDa, respectively. In vitro studies confirm that the PP can hide ligand FA to prevent it from binding to cells with FR alpha at pH 7.4 and shrink to expose FA at pH 5.5. In vivo studies demonstrate that our Trojan-horse targeting strategy can reduce the nonspecific uptake of the PP-FA-AN-FN by non-cancerous cells. Therefore, our PP-FA-AN-FN might be used as an accurately targeted MRI contrast agent. (C) 2015 Elsevier Ltd. All rights reserved.
语种英语
WOS记录号WOS:000362610600001
引用统计
被引频次:18[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/146591
专题中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Div Funct Mat & Nano Devices, Key Lab Magnet Mat & Devices, Ningbo 315201, Zhejiang, Peoples R China
2.Chinese Acad Sci, Dalian Inst Chem Phys, Div Biotechnol, Dalian 116023, Peoples R China
3.Inha Univ, Sch Med, Dept New Drug Dev, Inchon 400712, South Korea
推荐引用方式
GB/T 7714
Shen, Zheyu,Wu, Hao,Yang, Sugeun,et al. A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells[J]. BIOMATERIALS,2015,70:1-11.
APA Shen, Zheyu.,Wu, Hao.,Yang, Sugeun.,Ma, Xuehua.,Li, Zihou.,...&Wu, Aiguo.(2015).A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells.BIOMATERIALS,70,1-11.
MLA Shen, Zheyu,et al."A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells".BIOMATERIALS 70(2015):1-11.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Shen, Zheyu]的文章
[Wu, Hao]的文章
[Yang, Sugeun]的文章
百度学术
百度学术中相似的文章
[Shen, Zheyu]的文章
[Wu, Hao]的文章
[Yang, Sugeun]的文章
必应学术
必应学术中相似的文章
[Shen, Zheyu]的文章
[Wu, Hao]的文章
[Yang, Sugeun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。